Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

Feb 24, 2015
GenMark Reports Fourth Quarter and Full Year 2014 Results

Feb 23, 2015
GenMark Announces Appointment of New Board Members

View all releases »

Events

Mar 4, 2015 at 9:20 AM ET
Cowen and Company's 35th Annual Health Care Conference

Mar 2, 2015 at 2:50 PM ET
Raymond James' 36th Annual Institutional Investors Conference

View all events »

Related Links

Stock Quote
Price:
13.29
Change:
+ 0.20
Day High:
13.30
Day Low:
13.02
Volume:
176,500
NASDAQ
GNMK
4:00 PM ET on Mar 27, 2015
Delayed at least 20 minutes.
Provided by eSignal.